HPC Elects to Conduct Cost and Market Impact Review of Proposed New CVS and Mass General Brigham Primary Care Partnership
HPC will review potential implications on primary care access, quality, and cost
Massachusetts Hospitals Rapidly Scale Up Hospital at Home Model
Patient use increased tenfold from 2020 to 2024; Medicare’s participation set to expire September 30, 2025, absent immediate Congressional action
Statement from HPC Executive Director David Seltz on New HPC Board
“The Massachusetts Health Policy Commission (HPC) extends our sincere gratitude to Governor Maura Healey for the reappointment of HPC Board Chair Deborah Devaux and appointment of new and returning members to the HPC Board of Commissioners. The full slate of commissioners bring essential experience and policy expertise to the Board, and their leadership will help guide the HPC in addressing some of the Commonwealth’s most pressing challenges – including mounting affordability issues, workforce constraints, and threats to health care access."
HPC Shares New Research on Improving Affordability and Predictability in Cost Sharing, Announces the Launch of New Pharmaceutical and Health Planning Offices
Commissioners also voted to initiate the first retrospective cost and market impact review of Beth Israel Lahey Health’s 2019 formation
HPC Sets 2026 Health Care Benchmark at 3.6% and Calls for Renewed Commitment to Affordability Across Health Care System
HPC issues final report on cost and market impact review of new Dana-Farber-Beth Israel cancer care collaboration
Primary Care Task Force Launched To Stabilize and Strengthen Massachusetts Primary Care
New effort co-chaired by HPC and EOHHS tasked with recommending a new primary care spending target, improving patient access, and strengthening workforce
